<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03740620</url>
  </required_header>
  <id_info>
    <org_study_id>30-2018-76</org_study_id>
    <nct_id>NCT03740620</nct_id>
  </id_info>
  <brief_title>The Effect of Bevel Direction on the Pathway of the Nasotracheal Tube</brief_title>
  <official_title>The Effect of Bevel Direction on the Pathway of the Tracheal Tube in the Nasal Cavity During Nasotracheal Intubation: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the subjects are divided into two groups (group I: intervention group = the
      nasotracheal tube inserted with the bevel of the nasal tube facing the direction of the
      patient's head, and Group II: conventional group = the bevel of the tube toward the left side
      of the subject). After the endotracheal tube is introduced, a flexible endoscope is used to
      evaluate whether the tube is located below the inferior turbinate, i.e. in the lower pathway.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary outcome

        -  incidence of tracheal tube passing through the lower pathway (beneath the inferior
           turbinate and immediately above the nasal floor of the nostril) Secondary outcome

        -  intubation time

        -  incidence of epistaxis

        -  severity of bleeding

        -  Resistance during Insertion of the tracheal tube
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2019</start_date>
  <completion_date type="Anticipated">January 26, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 26, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of the tube in lower pathway</measure>
    <time_frame>right after completion of the intubation</time_frame>
    <description>incidence of tracheal tube passing through the lower pathway (beneath the inferior turbinate and immediately above the nasal floor of the nostril)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>intubation time</measure>
    <time_frame>from the start of the intubation to the completion of the intubation, which is confirmed by the appearance of end-tidal CO2 curve, up to 60 seconds</time_frame>
    <description>time to complete endotracheal intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence and severity of epistaxis</measure>
    <time_frame>right after completion of the intubation</time_frame>
    <description>incidence and severity of epistaxis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Epistaxis</condition>
  <condition>Intubation Complication</condition>
  <arm_group>
    <arm_group_label>intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the intervention group, a nasotracheal tube is inserted into the nostril with the bevel of the tube facing the cephalad direction of the patient.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the conventional group, a nasotracheal tube is inserted in a usual way, i.e., with the bevel of the tube facing the left side of the patient.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bevel facing the cephalad direction of the patient</intervention_name>
    <description>The bevel of the nasotracheal tube facing cephalad direction of the patient</description>
    <arm_group_label>intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bevel facing leftward of the patient</intervention_name>
    <description>The bevel of the nasotracheal tube facing the left side of the patient</description>
    <arm_group_label>conventional group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a patient who will take operation which needs nasotracheal intubation under general
             anesthesia

        Exclusion Criteria:

          -  a patient who didn't agree to participate in this study

          -  a patient who has a deformity of the nose

          -  a patient who has a history of severe epistaxis

          -  a patient who has coagulation problem

          -  a patient who has a history of the fracture or surgery of the skull base
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>07061</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tae Kyong Kim, MD</last_name>
      <phone>82-10-3750-5193</phone>
      <email>ktkktk@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Dong Wook Won, MD</last_name>
      <phone>82-10-3194-9471</phone>
      <email>won2501@naver.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>November 2, 2018</study_first_submitted>
  <study_first_submitted_qc>November 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2018</study_first_posted>
  <last_update_submitted>September 20, 2019</last_update_submitted>
  <last_update_submitted_qc>September 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Tae Kyong Kim</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>epistaxis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epistaxis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

